Revised outcome for BM dt. 04 November, 2026

Date: 5th November, 2026 The Secretary, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. Reference: Scrip Code: 524723 | ISIN: INE491D01017 Subject: Revised Outcome of Meeting of Board of Directors of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) held on 4th November, 2026 Respected Authorities, This is with reference to our earlier submission dated 4th November, 2026, regarding the Outcome of the Meeting of the Board of Directors of Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) ("the Company"), held on Wednesday, 4th November, 2026. In this regard, we wish to submit a revised disclosure in respect of Item A(1) under the heading "Proposed Rights Issue – Draft Letter of Offer", to accurately reflect the authorisation granted by the Board of Directors in favour of the Rights Issue Committee. Accordingly, the said item shall be read as follows: A. Proposed Rights Issue 1. Draft Letter of Offer In furtherance of the approval granted by the Board at its meeting held on 11th July, 2026, the Board authorised the Rights Issue Committee of the Company to review, finalise, approve and adopt the Draft Letter of Offer ("DLOF") in connection with the proposed Rights Issue of partly paid-up equity shares of the Company to the eligible equity shareholders, for an amount aggregating up to ₹21,000.00 lakhs (Rupees Two Hundred Ten Crore only), assuming full subscription, allotment and receipt of all call monies, pursuant to Section 62(1)(a) of the Companies Act, 2013 and the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations"). The Rights Issue Committee is further authorised to submit/file the DLOF with BSE Limited, being the Designated Stock Exchange, along with the application for obtaining in-principle approval, and to undertake all such acts, deeds and things as may be necessary or incidental thereto, in accordance with applicable laws. The final terms of the Rights Issue, including the issue price, rights entitlement ratio, amount payable on application and on subsequent call(s), and the record date, shall be decided by the Rights Issue Committee / the Board, as applicable, and will be intimated to the Stock Exchange separately, in accordance with the applicable SEBI regulations. All other disclosures contained in our earlier outcome dated 4th November, 2026, including the disclosures relating to the Postal Ballot, shall remain unchanged. The revised outcome is being submitted for your information and records. We request you to take the above on record. Thanking you, Yours faithfully, For Arvaya Healthcare Limited (Formerly Known as Bijoy Hans Limited) Kaushal Uttam Shah Managing Director DIN: 02175130 Place: Pune Date: 5th November, 2026